공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오분석(생물분석)용 실험실 자동화 시장 : 성장, 동향, 예측(2019-2024년)

Lab Automation in Bioanalysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 01월 상품 코드 347615
페이지 정보 영문
가격
US $ 4,250 ₩ 4,838,000 PDF (Single User License)
US $ 4,750 ₩ 5,407,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,830,000 PDF (Site License)
US $ 7,500 ₩ 8,538,000 PDF (Corporate License)


세계의 바이오분석(생물분석)용 실험실 자동화 시장 : 성장, 동향, 예측(2019-2024년) Lab Automation in Bioanalysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이오분석(생물분석)용 실험실 자동화 시장은 2019-2024년간 3.85%의 CAGR로 성장할 것으로 예측됩니다.

세계의 바이오분석(생물분석)용 실험실 자동화(Lab Automation) 시장에 대해 조사했으며, 시장 기회와 과제, 투자 분석, 성장 촉진요인 및 저해요인, 제공·분석기·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
  • 시장 성장 저해요인
  • 산업 밸류체인 분석
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 바이어/소비자의 협상력
    • 신규 참여업체의 위협
    • 대체 제품의 위협
    • 업계내의 경쟁
  • 기술 현황

제5장 시장 세분화

  • 제공별
    • 장비
    • 소프트웨어
  • 분석기별
    • 생화학 분석기
    • 면역 기반 분석기
    • 혈액 분석기
    • 세포 계수기(셀 카운터)
    • 응고계
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제6장 경쟁 상황

  • 기업 개요
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies
    • Beckman Coulter Inc.(Danaher Corporation)
    • Hamilton Company
    • Hudson Robotics Inc.
    • Becton, Dickinson and Company
    • Siemens Healthineers AG
    • Tecan Group Ltd.
    • Shimadzu Corporation

제7장 투자 분석

제8장 시장 기회 및 향후 동향

KSM 19.08.09

The lab automation in bioanalysis market was valued at USD 5.06 billion in 2020 and is expected to reach USD 7.10 billion by 2026, at a CAGR of 5.8% over the forecast period (2021 - 2026). Lab automation is required in bioanalysis applications, as manual and traditional handling can result in a corrupted or infected sample. The emergence of automated solutions, such as automated liquid handlers, automated plate handlers, and robotics, has eliminated the need for human intervention in bioanalysis laboratories by increasing accuracy and improving efficiency.

  • For clinical trials, it is sometimes imperative to monitor drug levels in subjects in real-time, which enables medical monitors and clinical investigators to adjust the dosing to meet the subject's needs and study requirements. Thus, clinical trials and diagnostics require bioanalysis technologies. Automated handling makes it easier to obtain error-free results. Owing to the rise in the number of clinical trials and studies and the growth in complexity, lab automation in bioanalysis is projected to experience significant demand.
  • Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Moreover, factors, such as technological innovations leading to device miniaturization and increased throughput and rising demand for personalized medicines, are significantly driving the market growth.
  • However, high capital requirements for setup will be a major hindrance to market growth.

Key Market Trends

Robotic Arms to be the Fastest Growing Equipment Segment

  • Robotic arms in lab automation are used for chemical analysis. Pharmaceutical companies are employing robots to move samples around the workspace for diagnosing chemical entities from the existing sample. Robotic arms are used for sample handling, coupled with new technologies, to eliminate errors.
  • The pharmaceutical industry has experienced increased use of robotic arms, as the synthesizing of samples with structural analysis can be done automatically. Robotic arms are used in applications, like biological and combinatorial chemistry for sample diagnosis, with automation increasing the market's standards.
  • Further, robotic arms also help in doing the mundane task in the laboratory set up saving time and energy of a human being doing that task. According to IFR, World Robotics 2018, sales of medical robots increased by 73% compared in 2016 to 2,931 units in 2017, accounting for a share of 2.7% of the total unit sales of professional service robots. The major reason identified for an increased sale has been the wide use in robotic surgery and laboratory automation in clinics.

North America to Hold Largest Market Share

  • A rise in the number of global clinical and pre-clinical studies has made the need for speedy analysis of samples imperative, making automation one of the key components contributing to the growth of the market.
  • Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Cost-effectiveness, owing to routine work, professional labor cost, and precise handling, is a variable that impacts the demand for these solutions.
  • Strict regulations by the US government and the FDA, the growing demand in the diagnostic market, and the increasing usage of discovery and research labs, owing to the rising presence of various diseases, such as cardiovascular diseases and neurological diseases in the region, have fueled the growth of the market. The US dominates the North American market and is the major revenue contributor in the region.

Competitive Landscape

The lab automation in bioanalysis market is consolidated. Major players have the maximum market share. Also, the players in the lab automation in bioanalysis market are increasingly competing against each other based on factors, such as product innovations and technological advances. Some of the key players include Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, PerkinElmer, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu, and Aurora Biomed, among others.

  • May 2019 - Beckman Coulter, announced the latest addition to its automation portfolio. The DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval. In the healthcare environment, laboratories are highly focused on enhancing patient care, by driving faster turnaround time, delivering quality results, and improving laboratory operations. The DxA 5000 helps laboratories meet these challenges through a collection of patented innovations that deliver rapid and consistent turnaround time, provide a new level of comprehensive pre-analytical sample quality detection, and reduce the number of manual processing steps to significantly improve laboratory efficiency.
  • September 2018 - Tecan successfully completed the acquisition of NuGEN Technologies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Personalized Medicines
    • 4.2.2 Technological Innovations Resulting in Improved Solutions
  • 4.3 Market Restraints
    • 4.3.1 High Capital Requirements for Setup
  • 4.4 Industry Value Chain Analysis
  • 4.5 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.5.1 Bargaining Power of Suppliers
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Threat of New Entrants
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry
  • 4.6 Technology Snapshot

5 MARKET SEGMENTATION

  • 5.1 By Offering
    • 5.1.1 Equipment
      • 5.1.1.1 Automated Liquid Handlers
      • 5.1.1.2 Automated Plate Handlers
      • 5.1.1.3 Robotic Arms
      • 5.1.1.4 AS/RS
      • 5.1.1.5 Vision Systems
    • 5.1.2 Software
  • 5.2 By Analyzers
    • 5.2.1 Biochemistry Analyzers
    • 5.2.2 Immuno-Based Analyzers
    • 5.2.3 Hematology Analyzers
    • 5.2.4 Cell Counters
    • 5.2.5 Coagulometers
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Agilent Technologies
    • 6.1.3 Beckman Coulter Inc. (Danaher Corporation)
    • 6.1.4 Hamilton Company
    • 6.1.5 Hudson Robotics Inc.
    • 6.1.6 Becton, Dickinson and Company
    • 6.1.7 Siemens Healthineers AG
    • 6.1.8 Tecan Group Ltd
    • 6.1.9 Shimadzu Corporation

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q